Search research articles
Contact Us
Filters
Showing results (101-110 of 283) with videos related to
Page
of 29
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 11, 2019
Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluations
Anja Wacker, Ulrike Bauder-Wüst, Martin Schäfer, et al.
The European Journal of Neuroscience
|
September 3, 2004
Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala
Andreas Ranft, Jörg Kurz, Martin Deuringer, et al.
Blood
|
February 8, 2007
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
Letizia Venturini, Karin Battmer, Mirco Castoldi, et al.
Leukemia
|
March 30, 2026
Differential mitochondrial priming by BCR::ABL1 in B-cell precursor acute lymphoblastic leukemia
Hanna Kirchhoff, Caroline Schoenherr, Lisa Fleischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2010
68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours
Matthias Eder, Stefan Knackmuss, Fabrice Le Gall, et al.
Clinical Nuclear Medicine
|
September 9, 2016
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
Christos Sachpekidis, Klaus Kopka, Matthias Eder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2021
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules
Ann-Christin Eder, Martin Schäfer, Jana Schmidt, et al.
Bone Marrow Transplantation
|
October 20, 2018
Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation
Anke Katrin Ziegler, Michael Abend, Matthias Port, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 18, 2015
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benešová, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Transplantation and Cellular Therapy
|
June 20, 2022
Increased Late Noncardiac Nonrelapse Mortality in Patients with Atrial Fibrillation Diagnosed During Their Hospital Stay for Allogeneic Stem Cell Transplantation
Catherina Lueck, Victoria Panagiota, Elke Dammann, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 283) with videos related to
Sort By:
Page
of 29
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 11, 2019
Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluations
Anja Wacker, Ulrike Bauder-Wüst, Martin Schäfer, et al.
The European Journal of Neuroscience
|
September 3, 2004
Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala
Andreas Ranft, Jörg Kurz, Martin Deuringer, et al.
Blood
|
February 8, 2007
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
Letizia Venturini, Karin Battmer, Mirco Castoldi, et al.
Leukemia
|
March 30, 2026
Differential mitochondrial priming by BCR::ABL1 in B-cell precursor acute lymphoblastic leukemia
Hanna Kirchhoff, Caroline Schoenherr, Lisa Fleischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2010
68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours
Matthias Eder, Stefan Knackmuss, Fabrice Le Gall, et al.
Clinical Nuclear Medicine
|
September 9, 2016
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
Christos Sachpekidis, Klaus Kopka, Matthias Eder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2021
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules
Ann-Christin Eder, Martin Schäfer, Jana Schmidt, et al.
Bone Marrow Transplantation
|
October 20, 2018
Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation
Anke Katrin Ziegler, Michael Abend, Matthias Port, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 18, 2015
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benešová, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Transplantation and Cellular Therapy
|
June 20, 2022
Increased Late Noncardiac Nonrelapse Mortality in Patients with Atrial Fibrillation Diagnosed During Their Hospital Stay for Allogeneic Stem Cell Transplantation
Catherina Lueck, Victoria Panagiota, Elke Dammann, et al.
Page
of 29